4-(1H-Pyrazol-1-yl)benzaldehyde → (2E)-3-[4-(1-Methyl-1H-pyrazol-3-yl)phenyl]-2-propenal
반응식
[CH3:1][N:2]1[CH:6]=[CH:5][C:4]([C:7]2[CH:14]=[CH:13][C:10]([CH:11]=O)=[CH:9][CH:8]=2)=[N:3]1.N1(C2C=C[C:23]([CH:24]=[O:25])=CC=2)C=CC=N1>>[CH3:1][N:2]1[CH:6]=[CH:5][C:4]([C:7]2[CH:14]=[CH:13][C:10](/[CH:11]=[CH:23]/[CH:24]=[O:25])=[CH:9][CH:8]=2)=[N:3]1참가 물질
3
실험 절차
The title compound was prepared by a procedure analogous to Reference Example 30 by substituting 4-(1-methyl-1H-pyrazol-3-yl)benzaldehyde (prepared as described in J. Med. Chem. 1998, 41, 2390) for the 4-(1H-pyrazol-1-yl)-benzaldehyde of Reference Example 30. MS 213 (M+H)+.
출처 및 근거
- ORD 기록
- ord-4a6493b6df8f4fe7bb84623c014fedcb
- 출처 데이터셋
- uspto-grants-2004_11
- 특허 번호
- US06825170B2
반응 노트
불러오는 중…